Abdalian charles h jr - direct investment history in Molecular insight pharmaceuticals inc

Filed on 2009-11-18 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001181431-09-052690.txt Sec File: edgar/data/1335290/0001181431-09-052690-index.htm

2009-11-17 Abdalian Charles H Jr (CIK 1335290) through Direct (Vp Of Finance And Cfo)

Invested in Molecular Insight Pharmaceuticals Inc bought 50000 shares at $0 remaining shares owned 50000

Employee Stock Option Right To Buy Molecular Insight Pharmaceuticals Inc Mipi exercise price 4.61 has valueitem expiration due date 2019-11-17 underlying security shares 50000 underlying security title Common Stock

f1 this option will vest and become exercisable in two installments upon acheivement by the reporting person of certain performance based milestones.


Filed on 2009-08-12 by Abdalian Charles H Jr SEC CIK 1335290 Form 4

Accession 0001209191-09-040401.txt Sec File: edgar/data/1335290/0001209191-09-040401-index.htm

2009-08-11 Abdalian Charles H Jr (CIK 1335290) through Direct (Vp Of Finance Cfo)

Invested in Molecular Insight Pharmaceuticals Inc bought 175000 shares at $0.00 remaining shares owned 175000

Employee Stock Option Right To Buy Molecular Insight Pharmaceuticals Inc Mipi exercise price 5.70 has valueitem expiration due date 2019-08-11 underlying security shares 175000 underlying security title Common Stock

f1 this option will vest in four equal annual installments beginning on august 10, 2010, subject to acceleration of vesting in the event of a change of control transaction or termination without cause.